SavedAdd your journal

Journals / Turkish journal of vascular surgery / 2021 / Cilt: 30 - Sayı: 1

The efficacy of endovenously cyanoacrylate adhesive for the treatment of great saphenous vein insufficiency and mid-term follow-up results

Kevser TURAL
Kazım ERGÜNEŞ
Pages
49–55
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, this procedure does not require the use of tumescent anesthesia and compression stockings.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to investigate the effectiveness and mid-term results of endovenous administration of n-butyl-2-cyanoacrylate (NBCA) in great saphenous vein (GSV) insufficiency.
📊
Key Findings & Data:Patients and methods: A total of 77 lower extremity GSVs of 65 patients (23 males, 42 females; mean age: 53.7±16.8 years; range, 18 to 89 years) treated endovenously using NBCA between June 2018 and June 2019 were retrospectively analyzed.
💡
Conclusion & Impact:In addition, this procedure does not require the use of tumescent anesthesia and compression stockings.
🔬Design:Survey & Empirical Study
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: This study aims to investigate the effectiveness and mid-term results of endovenous administration of n-butyl-2-cyanoacrylate (NBCA) in great saphenous vein (GSV) insufficiency. Patients and methods: A total of 77 lower extremity GSVs of 65 patients (23 males, 42 females; mean age: 53.7±16.8 years; range, 18 to 89 years) treated endovenously using NBCA between June 2018 and June 2019 were retrospectively analyzed. Clinical examination and color Doppler ultrasonographic examination were performed at 48 h and at 1, 3, 6, and 12 months after the procedure. The Comprehensive Classification System for Chronic Venous Disorders (CEAP) classification, Venous Clinical Severity Score (VCSS), and quality of life scores using the Aberdeen Varicose Vein Questionnaire (AVVQ ) were performed before and after the procedure. Results: Immediately after the procedure and at 48 h of follow-up, the GSV occlusion rate was 100%. The total occlusion rate was 97.4% at 12 months of follow-up. The mean VCSS improved from 5.9±1.5 at baseline to 0.8±0.6 at 12 months (p<001). The mean AVVQ scores improved from 15.4±3.6 at baseline to 3.8±0.7 at 12 months of follow-up (p<001). Conclusion: Endovenous treatment of GSV insufficiency with cyanoacrylate adhesive is a rapid and effective method and significantly improves the quality of life of patients. In addition, this procedure does not require the use of tumescent anesthesia and compression stockings.

🔖

Cite This Article

TURAL, K., ERGÜNEŞ, K. (2021). The efficacy of endovenously cyanoacrylate adhesive for the treatment of great saphenous vein insufficiency and mid-term follow-up results. Turkish journal of vascular surgery, Cilt: 30 - Sayı: 1, 49–55. https://ajindex.com/articles/417640

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health 1999;53:149-53
  2. Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F; VCP Coordinators. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol 2012;31:105-15
  3. Criqui MH, Jamosmos M, Fronek A, Denenberg JO, Langer RD, Bergan J, et al. Chronic venous disease in an ethnically diverse population: the San Diego Population Study. Am J Epidemiol 2003;158:448-56
  4. Rabe E. Vein Bonn Study. Phlebologie. 2006. p. 179-86
  5. Zöller B, Ji J, Sundquist J, Sundquist K. Family history and risk of hospital treatment for varicose veins in Sweden. Br J Surg 2012;99:948-53. 6. van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg 2009;49:230-9
  6. Critchley G, Handa A, Maw A, Harvey A, Harvey MR, Corbett CR. Complications of varicose vein surgery. Ann R Coll Surg Engl 1997;79:105-10
  7. Elias S, Raines JK. Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial. Phlebology 2012;27:67-72
  8. Almeida JI, Javier JJ, Mackay E, Bautista C, Proebstle TM. First human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord 2013;1:174-80
  9. Proebstle TM, Alm J, Dimitri S, Rasmussen L, Whiteley M, Lawson J, et al. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord 2015;3:2-7
  10. Kürşat Bozkurt A, Lawaetz M, Danielsson G, Lazaris AM, Pavlovic M, Olariu S, et al. European College of Phlebology guideline for truncal ablation. Phlebology 2020;35:73-83
  11. Koramaz İ, El Kılıç H, Gökalp F, Bitargil M, Bektaş N, Engin E, et al. Ablation of the great saphenous vein with nontumescent n-butyl cyanoacrylate versus endovenous laser therapy. J Vasc Surg Venous Lymphat Disord 2017;5:210-5
  12. Bozkurt AK, Yılmaz MF. A prospective comparison of a new cyanoacrylate glue and laser ablation for the treatment of venous insufficiency. Phlebology 2016;31(1 Suppl):106-13
  13. Linfante I, Wakhloo AK. Brain aneurysms and arteriovenous malformations: advancements and emerging treatments in endovascular embolization. Stroke 2007;38:1411-7
  14. Labenz J, Börsch